Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)

Monoclonal Antibody Drug Products: GMP Controls for Formulation and Filling Ensuring GMP Compliance in Formulation and Filling of Monoclonal Antibody Drug Products Monoclonal antibody (mAb) drug products are a vital class of biopharmaceuticals with significant therapeutic applications. Due to their complex nature and route of administration, robust Good Manufacturing Practice (GMP) controls are critical during…

Read More “Monoclonal Antibody Drug Products: GMP Controls for Formulation and Filling” »

Biologics Drug Product GMP: Protein Stability, Aggregation and Contamination Control Biologics Drug Product GMP: Ensuring Protein Stability, Aggregation and Contamination Control Across Dosage Forms Biologics drug products present critical manufacturing challenges distinct from small-molecule pharmaceuticals, stemming primarily from the complex nature of proteins and related macromolecules. Control of protein stability, prevention of aggregation, and robust…

Read More “Biologics Drug Product GMP: Protein Stability, Aggregation and Contamination Control” »

Handling and Filling of Highly Viscous or Sensitive Injectable Solutions: GMP Best Practices Step-by-Step Guide for Handling and Filling Highly Viscous or Sensitive Injectable Solutions Under GMP Within the pharmaceutical manufacturing landscape, the production of parenteral dosage forms—specifically highly viscous or sensitive injectable solutions—poses unique challenges. These products require strict adherence to Good Manufacturing Practice…

Read More “Handling and Filling of Highly Viscous or Sensitive Injectable Solutions” »

GMP for Lyophilized Products: Cake Appearance, Residual Moisture and Reconstitution Comprehensive GMP Guide for Lyophilized Products: Cake Appearance, Residual Moisture, and Reconstitution Lyophilized products, often referred to as freeze-dried pharmaceuticals, represent a critical dosage form within the sterile parenteral manufacturing sphere. Their unique requirements under Good Manufacturing Practice (GMP) guidelines demand precise control over formulation,…

Read More “GMP for Lyophilized Products: Cake Appearance, Residual Moisture and Reconstitution” »

Nasal Sprays and Drops: GMP Controls for Delivered Dose and Spray Pattern GMP Controls for Delivered Dose and Spray Pattern in Nasal Sprays and Drops: A Step-by-Step Guide The pharmaceutical industry continually evolves with diversified dosage forms, including solid oral preparations, parenteral injections, and topical products. Among topical dosage forms, nasal sprays and drops occupy…

Read More “Nasal Sprays and Drops: GMP Controls for Delivered Dose and Spray Pattern” »

Blow–Fill–Seal (BFS) Technology: GMP Controls for Ophthalmic and Inhalation Products GMP Controls for Blow–Fill–Seal (BFS) Technology in Ophthalmic and Inhalation Products: A Step-by-Step Guide Pharmaceutical manufacturers operating within the US, UK, and European Union must sustain rigorous quality standards across diverse dosage forms such as solid oral, parenteral, and topical products. Among sterilization and aseptic…

Read More “Blow–Fill–Seal (BFS) Technology: GMP Controls for Ophthalmic and Inhalation Products” »

Multi-Dose Ophthalmic Products: Preservative Efficacy and Microbial Limits Multi-Dose Ophthalmic Products: Ensuring Preservative Efficacy and Controlling Microbial Limits In the pharmaceutical production of multidose ophthalmic products, addressing preservative efficacy and establishing appropriate microbial limits are of paramount importance to meet stringent GMP requirements across the US, UK, and EU markets. These products present unique microbiological…

Read More “Multi-Dose Ophthalmic Products: Preservative Efficacy and Microbial Limits” »

Ophthalmic Product GMP: Particulate, pH and Osmolality Critical Controls Ophthalmic Product GMP: Particulate, pH and Osmolality Critical Controls in Dosage Forms The manufacturing of ophthalmic pharmaceutical products demands rigorous compliance with Good Manufacturing Practice (GMP) requirements specific to dosage forms. These products, being highly sensitive formulations administered directly to the eye, require strict control over…

Read More “Ophthalmic Product GMP: Particulate, pH and Osmolality Critical Controls” »

Viral Vector and Gene Therapy Drug Products: ATMP-Specific GMP Challenges Viral Vector and Gene Therapy Drug Products: Navigating ATMP-Specific GMP Challenges Advanced Therapy Medicinal Products (ATMPs), such as viral vector-based gene therapies, present unique challenges in Good Manufacturing Practice (GMP) compliance. Due to their complex and sensitive nature, these drug products must adhere to stringent…

Read More “Viral Vector and Gene Therapy Drug Products: ATMP-Specific GMP Challenges” »

Nebulizer Solutions and Suspensions: Sterility, Preservatives and Device Interface Nebulizer Solutions and Suspensions: Ensuring Sterility, Preservative Efficacy, and Device Compatibility under GMP The manufacturing, quality assurance, and regulatory compliance of nebulizer solutions and suspensions present unique challenges within pharmaceutical Good Manufacturing Practice (GMP) frameworks. These inhalation products must fulfill stringent criteria for sterility, preservative integrity,…

Read More “Nebulizer Solutions and Suspensions: Sterility, Preservatives and Device Interface” »